Marrone Bio Innovations

Marrone Bio Innovations CapEx/OCF

Delisted

The CapEx to Operating Cash Flow Ratio of Marrone Bio Innovations (MBII) as of Nov 18, 2026 is -10.97 %. In the previous year, CapEx to Operating Cash Flow Ratio was -3.50 % — a change of 213.26% (lower).

CapEx/OCF

-10.97 %

YoY

213.26%

Last updated:

CapEx to Operating Cash Flow Ratio of Marrone Bio Innovations is 2021 -10.97 % . CapEx to Operating Cash Flow Ratio of Marrone Bio Innovations was 2020 -3.50 % . It decreases by 213.26% lower compared to the previous year.

The Marrone Bio Innovations CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2014
-36.18 USD
Jan 1, 2015
-36.18 USD
Jan 1, 2016
-0.86 USD
Jan 1, 2017
-4.03 USD
Jan 1, 2018
-2.99 USD
Jan 1, 2019
-1.39 USD
Jan 1, 2020
-3.50 USD
Jan 1, 2021
-10.97 USD
The Marrone Bio Innovations CapEx/OCF history
YEARCapEx/OCFYoY
-10.97 %+213.26%
-3.50 %+152.52%
-1.39 %-53.54%
-2.99 %-25.95%
-4.03 %+368.94%
-0.86 %-97.62%
-36.18 %0.00%
-36.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marrone Bio Innovations stock

CapEx to Operating Cash Flow Ratio of Marrone Bio Innovations is -10.97 % in 2021.

CapEx to Operating Cash Flow Ratio of Marrone Bio Innovations changed from -3.50 % to -10.97 %, representing a 213.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Marrone Bio Innovations since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Marrone Bio Innovations with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Marrone Bio Innovations

All Key Metrics — Marrone Bio Innovations